EVOLUTION OF IMMNUNO-ONCOLOGY CLINICAL TRIALS IN A TERTIARY UNIVERSITY HOSPITAL
CP-194
EVALUATION OF ACCESS TO OFF-LABEL NEW THERAPIES PHARMACOLOGICAL FIELD AND THE HOSPITAL AND ECONOMIC IMPACT
CP-193
CLINICAL AND ECONOMIC IMPACT OF PHARMACISTS' INTERVENTIONS RELATED TO ANTIMICROBIALS IN THE HOSPITAL SETTING: A SYSTEMATIC REVIEW
CP-192
ASSESSMENT OF MEDICAL COMPUTERISED PRESCRIPTIONS IN GERIATRICS USING STOPP/START CRITERIA
CP-191
PRESCRIPTION EVALUATION OF HOSPITALISED PATIENTS AT A DISTRICT HOSPITAL, USING A PLATFORM THAT SUPPORTS ANTIMICROBIAL PRESCRIPTION: A PILOT ANALYSIS
CP-189
ADHERENCE TO ABIRATERONE AND ENZALUTAMIDE IN PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER
CP-187
EFFICACY, SAFETY AND COST OF POMALIDOMIDE IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA
CP-185
AN INNOVATIVE TREATMENT ADHERENCE TOOL
CP-184
CORRELATIONS OF VANCOMYCIN CLEARANCE DURING INTERMITTENT INFUSION WITH MEASURED AND ESTIMATED CREATININE CLEARANCE IN CRITICALLY III PATIENTS: 6-HOUR URINE COLLECTION MAY BE BENEFICIAL
CP-182
POTENTIAL ECONOMICAL IMPACT OF BIOSIMILAR ADLIMUMAB
CP-179
EFFECTS OF REIMBURSEMENT CHANGES ON USE OF ERYTHROPOIESIS-STIMULATING AGENTS IN DIALYSIS PATIENTS
CP-177
INDIVIDUAL PARENTERAL NUTRITION: PHARMACIST WORK AS A MULTIDISCIPLINARY TEAM MEMBER
CP-171
BIOLOGICAL DRUGS: PERSISTENCE RATE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SPONDYLARTHRITIS
CP-170
EVALUATION OF ANGIOTENSINOGEN M235T AND T174M POLYMORPHISMS, DEMOGRAPHIC AND CLINICAL FACTORS IN NEW-ONSET DIABETES AFTER LIVER TRANSPLANTATIONS IN IRANIAN PATIENTS
CP-168
ECONOMIC IMPACT OF CLINICAL PHARMACISTS' INTERVENTIONS ON ANTIMICROBIAL THERAPY IN CRITICALLY ILL PATIENTS
